The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety analysis of FOLFOX as adjuvant chemotherapy for stage III colon cancer in phase II study (NORTH/HGCSG1003): Detailed analysis of peripheral sensory neuropathy.
 
Susumu Sogabe
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo; Eisai; Merck Serono; Takeda
 
Satoshi Yuki
Speakers' Bureau - Yakult Pharmaceutical
 
Hiraku Fukushima
No Relationships to Disclose
 
Norihiko Takahashi
No Relationships to Disclose
 
Toshiaki Shichinohe
No Relationships to Disclose
 
Takaya Kusumi
No Relationships to Disclose
 
Fumitaka Nakamura
No Relationships to Disclose
 
Ichiro Iwanaga
No Relationships to Disclose
 
Kazuteru Hatanaka
No Relationships to Disclose
 
Kencho Miyashita
No Relationships to Disclose
 
Jun Konno
No Relationships to Disclose
 
Kazuhito Uemura
No Relationships to Disclose
 
Masaaki Nenohi
No Relationships to Disclose
 
Masaya Kina
No Relationships to Disclose
 
Naoya Sakamoto
No Relationships to Disclose
 
Akinobu Taketomi
No Relationships to Disclose
 
Satoshi Hirano
No Relationships to Disclose
 
Toraji Amano
No Relationships to Disclose
 
Yoichi M Ito
No Relationships to Disclose
 
Yoshito Komatsu
Speakers' Bureau - Yakult Pharmaceutical
Research Funding - Yakult Pharmaceutical (Inst)